Establishing secure connection…Loading editor…Preparing document…

Research Mask Study

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

RESEARCH MASK STUDY AGREEMENT

This Research Mask Study Agreement (the "Agreement") is entered into on this date: Month Day Year , by and between Client Name: , with principal place of business at (hereinafter "Sponsor"), and Research Institution Name: , Principal Investigator: , address: (hereinafter "Investigator" or "Institution").

RECITALS

WHEREAS, Sponsor seeks to evaluate the performance, usability, and human factors associated with face mask prototypes in a controlled research setting and desires to engage Investigator to perform such research under the terms set forth herein; and

WHEREAS, Investigator represents that it has the necessary expertise, facilities, personnel, and Institutional Review Board oversight (where required) to conduct the Research Mask Study in accordance with applicable laws, ethical standards, and accepted scientific practices; and

WHEREAS, the parties desire to define their respective rights and obligations with respect to the conduct of the Study, ownership and use of data, confidentiality, payment, and other matters as set forth in this Agreement.

SCOPE OF WORK

Investigator shall conduct the Study in accordance with the scope described above and any approved study protocol. Investigator shall adhere to all applicable laws, regulations and ethical standards, including obtaining and maintaining informed consent, data protection, and Institutional Review Board approval where required.

Investigator affirms that the Study has received IRB approval or an equivalent ethics determination and will maintain such approvals during the Study.

PAYMENT TERMS

Sponsor will pay Investigator in accordance with the payment schedule above. All undisputed amounts not paid when due shall accrue interest at the rate specified in the Late Payment field, or in the absence of a specified rate, at 1.5% per month. Payments are subject to presentation of a proper invoice and any reasonable supporting documentation.

TERM AND TERMINATION

The term of this Agreement shall commence on the Start Date: Month Day Year , and terminate on the End Date: Month Day Year , unless earlier terminated as provided below.

Either party may terminate this Agreement for material breach by the other party if the breaching party fails to cure the breach within thirty (30) days after receipt of written notice specifying the breach. Sponsor may terminate immediately for Investigator's failure to maintain required approvals or for serious safety concerns. Upon termination, Sponsor shall pay Investigator for Study work performed and documented through the effective date of termination in accordance with the Payment Terms.

CONFIDENTIALITY

"Confidential Information" means non-public information disclosed by one party ("Disclosing Party") to the other ("Receiving Party"), whether oral, written, or electronic, that is designated as confidential or which reasonably should be understood to be confidential given the nature of the information and the circumstances of disclosure. Confidential Information excludes information that (a) is or becomes public other than by breach of this Agreement; (b) was known to the Receiving Party without restriction prior to disclosure; (c) is lawfully obtained from a third party without restriction; or (d) is independently developed by the Receiving Party without use of the Disclosing Party's Confidential Information.

The Receiving Party shall (i) hold Confidential Information in confidence using at least the same degree of care it uses to protect its own confidential information but no less than reasonable care; (ii) not disclose Confidential Information to any third party except as expressly permitted under this Agreement; and (iii) use Confidential Information solely for the performance of the Study. The obligations of confidentiality shall survive termination of this Agreement for years.

DATA, PUBLICATION, AND INTELLECTUAL PROPERTY

Unless otherwise agreed in writing, Sponsor shall retain exclusive ownership of all raw study data and any proprietary designs provided by Sponsor. Investigator may use aggregated, de-identified Study results for scientific publications or presentations only with Sponsor's prior written consent, which shall not be unreasonably withheld. Any inventions or improvements specifically arising from Sponsor-provided materials and funded activities shall be owned as follows: Sponsor owns inventions directly relating to Sponsor materials; Investigator owns inventions solely derived from Investigator's independent methods. Specific ownership and licensing obligations may be documented in separate addenda.

Publication requests shall be submitted to Sponsor at least days prior to submission to permit review for confidential information and protection of patentable subject matter. Sponsor's review may result in redaction of Confidential Information or a short delay to permit filing of patent applications.

INDEMNIFICATION AND INSURANCE

Each party (the "Indemnifying Party") shall indemnify, defend and hold harmless the other party (the "Indemnified Party") from and against third-party claims arising from the Indemnifying Party's negligence or willful misconduct in connection with its performance under this Agreement. Investigator shall maintain professional liability and general liability insurance appropriate to the Study and shall provide proof of insurance upon reasonable request.

GOVERNING LAW

This Agreement shall be governed by and construed in accordance with the laws of the State of , without regard to its conflicts of law principles.

ENTIRE AGREEMENT; AMENDMENT

This Agreement, including any exhibits or attachments expressly incorporated herein, constitutes the entire agreement between the parties with respect to the Study and supersedes all prior and contemporaneous agreements, understandings, and representations. Any amendment or modification of this Agreement must be in writing and signed by authorized representatives of both parties.

NOTICES

Notices under this Agreement shall be in writing and delivered to the addresses set forth above or to such other address as a party may designate by notice in accordance with this section. Notice is effective upon receipt.

MISCELLANEOUS

If any provision of this Agreement is held to be invalid or unenforceable, the remaining provisions shall remain in full force and effect. Neither party may assign its rights or obligations under this Agreement without the prior written consent of the other party, except that Sponsor may assign to an affiliate or successor without consent so long as Sponsor provides prior notice to Investigator.

Sponsor:

By:

Date:

Investigator / Institution:

By:

Date:

Enter text✕
Prepare your document for signing right on this page
  • 01 Edit the text and complete the fields
  • 02 Click Sign Now and on the next screen add recipients and signature fields in SignNow
  • 03 Start your free trial to sign and send your doc
Sign Now

What the Research Mask Study document is and when it’s used

The Research Mask Study is a structured document used to record study details, participant information, masking procedures, and consent acknowledgements for clinical or observational research evaluating face‑covering interventions. It combines protocol identifiers, eligibility screening, masking assignment, data collection fields, and signature blocks so sponsors, investigators, and oversight bodies have a single reproducible record of enrollment and participant agreement.

Why a clear Research Mask Study form matters

A standardized Research Mask Study reduces administrative ambiguity, supports regulatory review, and documents participant consent and masking procedures in a consistent format that is auditable and reproducible across sites.

Why a clear Research Mask Study form matters

Primary users and stakeholders for the Research Mask Study

The document is used by people responsible for study conduct, compliance, and participant interaction.

  • Principal investigators and sub‑investigators who confirm eligibility and oversight responsibilities for participants.
  • Research coordinators and study staff who collect baseline data, document masking assignments, and maintain source records.
  • Institutional offices and IRB/ethics reviewers that audit documentation, consent records, and protocol adherence.

Roles vary by institution; maintain role-based copies and access logs to support audits and monitoring visits.

Core components to include in a professional Research Mask Study form

A comprehensive form groups identifying metadata, protocol summary, masking procedures, eligibility checks, data collection fields, and signature elements to ensure completeness and regulatory readiness.

Study ID

Unique protocol identifier and version so every page references the same approved study document and amendment history.

Protocol summary

Brief objective, design, and primary endpoints so site staff and participants can quickly confirm relevance and scope.

Masking procedures

Detailed instructions for assigned mask type, fitting, wear time, and monitoring to ensure consistent implementation across participants.

Eligibility checklist

Concise inclusion/exclusion items with checkboxes to confirm screening decisions and any required pre‑enrollment tests.

Data fields

Standardized fields for demographics, baseline measures, adverse events, and visit dates to support downstream analysis and reporting.

Consent and signatures

Designated areas for participant acknowledgement, witness or proxy details, and investigator attestation with date stamps.

Stepwise process to complete and finalize the Research Mask Study form

Complete the Research Mask Study in a consistent sequence to maintain data integrity and to satisfy ethical and regulatory oversight.

  • 01
    Review protocol: Confirm applicable version and consent language before enrolling a participant.
  • 02
    Screen participant: Use the eligibility checklist to document inclusion and exclusion criteria.
  • 03
    Assign masking: Record mask type, instructions given, and any fitting checks performed.
  • 04
    Obtain signature: Have participant sign and date; capture witness or authentication evidence as required.

Typical digital workflow for issuing and collecting the Research Mask Study

An organized digital workflow reduces errors: upload a master form, place fields, assign signers, authenticate, and archive with an audit trail.

  • Upload master: Add the approved form version to the signing platform.
  • Place fields: Add name, date, checkbox, and signature fields in the correct order.
  • Assign signers: Enter participant and witness roles and contact information.
  • Capture audit: Ensure timestamps, IP, and authentication are recorded at completion.

Recommended online setup options for study forms

Configure validation, signer order, and authentication to match your IRB-approved process before distributing electronic forms to participants.

Field | Configuration Validation rule | Required
Required fields Mark participant name, DOB, consent checkbox as required
Authentication Use email link or SMS code depending on risk level
Save drafts Allow staff to save in-progress records for later completion
Notifications Notify PI and coordinator on completion

Platform and format considerations for digital completion

Confirm platform compatibility, integrations, and supported file types before rolling out the form to sites.

  • File types: PDF, DOCX, HTML supported
  • Integrations: Salesforce, NetSuite, Google Workspace
  • Browser support: Modern Chrome, Edge, Safari

Verify mobile responsiveness and offline capabilities for field staff; ensure any platform used supports required audit trails and access controls.

Key timing checkpoints for handling the Research Mask Study

Adhere to regulatory and institutional timing: obtain approvals before recruitment and meet reporting windows for safety events and continuing review.

IRB approval deadline:

Obtain approval before any participant contact or enrollment

Consent timing:

Obtain informed consent prior to study procedures or data collection

Adverse event reporting:

Report serious events per IRB requirements, often within 24–72 hours

Continuing review:

Submit annual status reports as required by the approving IRB

Data lock:

Follow sponsor timelines for database lock and final submissions

Common errors to avoid when preparing the Research Mask Study

  • Mismatched participant names or dates between consent and source records that complicate verification and linkage.
  • Incomplete masking procedure details that allow site‑to‑site variation and undermine consistency of intervention delivery.
  • Missing authentication evidence for electronic signatures, making attribution and auditability unclear during monitoring.
  • Failing to document witness or proxy authority where state or sponsor rules require additional attestations.

Potential risks and consequences of incorrect or incomplete study records

Regulatory risk: Possible IRB noncompliance findings
Data integrity: Questionable dataset validity
Participant risk: Miscommunication about intervention
Privacy breach: Potential HIPAA exposure
Reputational harm: Sponsor or site credibility loss
Legal exposure: Contractual or liability claims

Security and compliance measures for storing Research Mask Study records

Encryption in transit: TLS 1.2/1.3
Encryption at rest: AES-256
Audit trails: Detailed signing logs retained
Access controls: Role-based permissions required
HIPAA readiness: BAA required for PHI handling
Record retention: Tamper-evident storage and journaling

Typical signers and their responsibilities

Principal Investigator

Dr. Jane Smith, PI. Responsible for overall study conduct, final verification of eligibility and consent, and for ensuring local regulatory compliance during enrollment and follow‑up.

Research Coordinator

Alex Martinez, Coordinator. Handles day-to-day participant interactions, completes screening checklists, documents mask assignment and fitting checks, and ensures signatures and timestamps are recorded accurately.

Practical examples of how the Research Mask Study is used

Two concise examples show common real-world scenarios for study form use and documentation flow.

Single‑site outpatient trial

A community clinic enrolls eligible adults using the form to document screening and masking instructions

  • Mask type assigned once per participant at baseline
  • Completed forms are archived with digital signatures and stored for sponsor monitoring visits and audits.

Multi‑site observational cohort

A coordinated network uses a standardized template to harmonize data collection across sites

  • Field staff complete eligibility and mask fit sections at each visit
  • Central data management reconciles signed records and supplies audit exports for the steering committee.

Practical tips to ensure accurate and efficient completion

Adopt consistent conventions and verification steps to reduce rework and improve audit readiness when collecting study data and signatures.

Use a single approved version
Distribute and use only the IRB‑approved form version. Track amendments centrally and note the version and effective date on every completed copy to prevent mixing records across versions.
Train site personnel
Provide brief, role‑specific training on completing the form fields, masking procedures, and signature collection so that staff understand what must be verified before enrollment.
Standardize mask descriptions
Record make, model, lot number and fitting instructions uniformly so device differences cannot confound outcomes or data interpretation across sites.
Preserve authentication data
Retain signer authentication evidence (email, SMS, ID check) alongside the signed record to support attribution and satisfy monitoring and auditing needs.

Comparing electronic signatures to wet‑ink for the Research Mask Study

Choose the signing method that meets legal, operational, and IRB expectations for authenticity, storage, and auditability.

Criterion Electronic Signature Wet Ink
Legal validity
Attribution evidence audit trail handwritten name
Storage encrypted digital physical file
Speed faster slower

eSignature vendor pricing comparison for study workflows

Basic pricing and feature availability for common eSignature vendors to help align platform selection with study volume and compliance needs.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial, no credit card No No Yes, limited Yes, limited
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
Envelope Cap No cap 100 envelopes/user/year Varies by plan Varies by plan Varies by plan

Frequently asked questions about completing and eSigning the Research Mask Study

Answers to common questions about legal validity, authentication, notarization, amendments, and record retention for study forms.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users
Sign Now
Company
Forms
Pricing
Resources
Knowledge base
Other Products
© 2026 airSlate Inc. All rights reserved.